Acura Pharmaceuticals, Inc. received loans of $41,607 and $100,000 on October 19 and October 30, 2026, respectively, from Abuse Deterrent Pharma, LLC. These loans, combined with previous loans and $2,319,279 under the November 10, 2022 Amended Consolidated and Restated Secured Pr